Home › Frost & Sullivan Recognizes KAER's Game-Changing Innovating Aerosol Drug Delivery Methods For High-Dose Respiratory Disease Therapeutics
 

Keywords :   


Frost & Sullivan Recognizes KAER's Game-Changing Innovating Aerosol Drug Delivery Methods For High-Dose Respiratory Disease Therapeutics

2013-02-27 02:15:32| drugdiscoveryonline Home Page

Based on its recent analysis of the aerosol drug delivery technology market, Frost & Sullivan recognizes KAER Biotherapeutics with the 2012 North America Frost & Sullivan Award for Technology Innovation for SUPRAER

Tags: methods delivery drug disease

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
14.11 HUNTER × HUNTER 135
14.11 2023 25.5cm
14.112014
14.11FIREWING PEGASUS
14.11 2024
14.11 1-15
14.11 90s AXO SPORTS BMX motocross
14.11
More »